Cabaletta Bio, Inc.
Cabaletta Bio, Inc.（CABA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
caba · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$32.00
Consensus
$16.33
+410.3% upside
Low
$3.00
Median: $14 · Last Close: $3.20
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$16.33
410.3% upside
High Target
$32
900.0%
Low Target
$3
-6.3%
Current Price
$3.20
as of today
Based on analyst price targets, the CABA stock price prediction for the next 12 months ranges from $3 to $32. The consensus CABA price forecast of $16.33 implies 410.3% upside from the current price of $3.20.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.13 | ↓ 2.33% |
1-day model range: $3.08–$3.17. Peak: $3.17 (-2.33%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CABA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2026-05-04 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-03-24 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-24 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2025-10-31 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-10-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-05 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-08-14 | Citigroup | Maintains | Buy→Buy |
| 2025-08-08 | Guggenheim | Maintains | Buy→Buy |
| 2025-08-08 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
Wall Street analysts have recently issued updated ratings on Cabaletta Bio, Inc. (CABA) stock. Of the recent 76 rating actions, 1 were upgrades and 3 were downgrades. 12 analysts currently cover CABA.
分析师推荐趋势
CABA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$3M
↓ 96.1% YoY
Revenue Next Year
$1M
↓ 71.5% YoY
EPS This Year
$-1.38
EPS Next Year
$-1.27
↓ 8.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CABA EPS of $-1.38 for the current fiscal year, based on estimates from 5 analysts. The CABA revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CABA 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CABA 的共识目标价为 $16.33（+410.3% 上行空间），分析师共识为 Buy。
CABA 的短期预测（明日）为 $3.13（-2.33%）。
Cabaletta Bio, Inc. 在 NASDAQ 上市，代码 CABA。CABA 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
CABA 预测 · 8 个问题根据 12 位华尔街分析师，CABA 的 12 个月平均目标价为 $16.33，最高 $32.00、最低 $3.00。若有图表，中位目标价可在上方查看。相对当前价 $3.20，隐含约 +410.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.